Does captopril change oxidative stress in puromycin aminonucleoside nephropathy? (Q31476857)

2 July 2017

Does captopril change oxidative stress in puromycin aminonucleoside nephropathy? (English)

1 reference

2 July 2017

Djordjevic VB

1

1 reference

2 July 2017

Cosic V

2

1 reference

2 July 2017

Pavlovic D

3

1 reference

2 July 2017

Vlahovic P

4

1 reference

2 July 2017

Jevtovic T

5

1 reference

2 July 2017

Kocic G

6

1 reference

2 July 2017

Savic V

7

1 reference

2 July 2017

1 January 2000

1 reference

2 July 2017

1 reference

2 July 2017

22

1 reference

2 July 2017

5

1 reference

2 July 2017

535-544

1 reference

Genetic factors in focal segmental glomerulosclerosis.

2 July 2017

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100100895

Effects of captopril on morphologic changes in kidney of spontaneously hypertensive rats with adriamycin nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100100895

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100100895

Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100100895

Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100100895

Evidence for suitability of glutathione peroxidase as a protective enzyme: Studies of oxidative damage, renaturation, and proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100100895

Reduction of proteinuria by angiotensin converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100100895

Chronic glomerulonephritis: nonimmunologic mechanisms of progressive glomerular damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100100895

Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100100895

Metabolism of aminonucleoside-8-14C in the rat and guinea pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100100895

Evaluation of the ability of the angiotensin-converting enzyme inhibitor captopril to scavenge reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100100895

Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100100895

Angiotensin converting enzyme inhibitors as oxygen free radical scavengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100100895

Superoxide scavenging by thiol/copper complex of captopril--an EPR spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100100895

Antioxidant and prooxidant properties of captopril and enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100100895

The prooxidant properties of captopril

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100100895

Comparative modulating effects of captopril, diltiazem, dietary calcium and pyridoxal-5'-phosphate on gentamicin-induced nephrotoxicity in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100100895

21 January 2018

Identifiers

DOI

10.1081/JDI-100100895

1 reference

2 July 2017

1 reference